Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Imperiale named IU’s first Lawrence Lumeng Professor in Gastroenterology and Hepatology

INDIANAPOLIS — Regenstrief Institute investigator Thomas F. Imperiale, M.D., has been named the inaugural Lawrence Lumeng Professor in Gastroenterology and Hepatology at Indiana University School of Medicine. Dr. Imperiale is an internationally respected health services researcher and a clinical gastroenterologist.

Dr. Imperiale’s research, which has been funded by the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Department of Veterans Affairs and other organizations, focuses on developing and testing screening strategies for colorectal cancer based on risk factors. His findings have been published in highly regarded journals including the New England Journal of Medicine, Journal of the American Medical Association, Annals of Internal Medicine and Gastroenterology.

In addition to the IU School of Medicine, Dr. Imperiale holds appointments with the Regenstrief Institute’s William M. Tierney Center for Health Services Research, the IU Center for Health Services and Outcomes Research, the VA Center for Health Information and the Indiana University Melvin and Bren Simon Cancer Center.

The new endowed professorship is named for Lawrence Lumeng, M.D., who was the Division Director of imperiale-t01-5x7-jpgGastroenterology and Hepatology in the Department of Medicine at the IU School of Medicine from 1983 to 2007. Under Dr. Lumeng’s leadership, the division pursued excellence in patient care and innovation in research and education.

“Dr. Lumeng hired me twenty years ago and I joke that he knew what I was going to do — outcomes research — before I knew it,” said Dr. Imperiale. “Screening for colorectal cancer saves lives. I am working to apply knowledge and technology to tailor colorectal cancer screening to an individual’s specific risk factors so that we can offer choices that are appropriate to that risk making screening more personalized, efficient, and in many cases, permissive and flexible.”

Dr. Imperiale is a graduate of City University of New York, earned his medical degree at New York University, was a resident in internal medicine at Case Western Reserve University and completed fellowships in clinical epidemiology at Yale University and in gastroenterology at Case Western Reserve University. Since joining IU in 1996 and the Regenstrief Institute in 2000 he has mentored more than thirty medical residents, fellows and junior faculty members. He is a recipient of the Regenstrief Institute’s Outstanding Investigator Award and the IU Trustee Teaching Award.

Related News

Apr 05, 2021 • News
POLST and other advance medical planning should not be a one-time conversation
IU and Regenstrief studies find mismatch between recorded and current treatment preferences The high incidence of COVID-19 and resulting sudden changes in the health of many long-stay nursing home residents across the country have amplified the importance of advance care planning and the need for periodic review of the process, especially as widespread vaccination changes…
Continue Reading >
Mar 31, 2021 • News
Data modernization: LOINC director discusses how data standards are rising to challenges
LOINC® Executive Director Marjorie Rallins, DPM, M.S., participated in a panel discussion during the Office of the National Coordinator for Health Information Technology (ONC) 2021 annual meeting. More than 1,000 health information technology partners signed up to attend the two-day virtual event.   Dr. Rallins was on a panel called Meeting Data Modernization Needs: Standards Development Organizations Rise to the Challenge. She and other experts discussed how standards development…
Continue Reading >